Should ▼dabigatran replace warfarin for stroke prevention in AF?

Drug and Therapeutics Bulletin

Volumn 49, Issue 10, 2011, Pages 114-117

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; CARBAMAZEPINE; DABIGATRAN; PHENYTOIN; QUINIDINE; RIFAMPICIN; VERAPAMIL; WARFARIN; ANTICOAGULANT AGENT; BENZIMIDAZOLE DERIVATIVE; DABIGATRAN ETEXILATE; PYRIDINE DERIVATIVE;

ANEMIA; ARTICLE; BLEEDING; COST EFFECTIVENESS ANALYSIS; CREATININE CLEARANCE; DEATH; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG COST; DRUG HALF LIFE; DRUG METABOLISM; DRUG SAFETY; DRUG WITHDRAWAL; DYSPEPSIA; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; HYPERICUM PERFORATUM; RANDOMIZED CONTROLLED TRIAL (TOPIC); STROKE; TREATMENT INDICATION; TREATMENT OUTCOME; CLINICAL TRIAL (TOPIC); REVIEW;

ANTICOAGULANTS; ATRIAL FIBRILLATION; BENZIMIDAZOLES; CLINICAL TRIALS AS TOPIC; HUMANS; PYRIDINES; STROKE; WARFARIN;

EID: 82355186232     PISSN: 00126543     EISSN: 17555248     Source Type: Journal    
DOI: 10.1136/dtb.2011.02.0060     Document Type: Article

References (20)

1. Anticoagulation with dabigatran or rivaroxaban. DTB 2009; 47: 116-20.
2. The Information Centre, 2010. Prevalence. Quality and Outcomes Framework (QOF) for April 2009 - March 2010, England [online]. Available: http://www.ic.nhs.uk/webfiles/QOF/2009-10/Prevalence%20tables/QOF0910_National_Prevalence_Aug_2011.xls [Accessed 22 September 2011].
3. Camm AJ et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31: 2369-429.
4. Keeling D et al. Guidelines on oral anticoagulation with warfarin - fourth edition. Br J Haematol 2011; doi:10.1111/j.1365-2141.2011.08753.x.
5. National Collaborating Centre for Chronic Conditions, 2006. Atrial fibrillation. National clinical guideline for management in primary and secondary care [online]. Available: http://www.nice.org.uk/nicemedia/live/10982/30055/30055.pdf. [Accessed 22 September 2011].
6. Olesen JB et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ 2011; 342: d124.
7. Pisters R et al. A novel user-friendly score (HAS-BLED) to assess one-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 2010; doi 10.1378/chest.10-0134.
8. Self-monitoring for patients on warfarin? DTB 2009; 47: 98-101
9. Pradaxa 150mg hard capsules. Summary of product characteristics, EU. Boehringer Ingelheim International GmbH, August 2011.
10. Connolly SJ et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139-51.
11. Connolly SJ et al. Newly identified events in the RE-LY trial. N Engl J Med 2010; 363: 1875-6.
12. Wallentin L et al. Efficacy and safety of dabigatran compared with warfarin at different levels ofinternational normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial. Lancet 2010; doi: 10.10.1016/S0140-6736(10)61194-4.
13. Gage BF. Can we rely on RE-LY? N Engl J Med 2009; 361: 1200-2.
14. Jacobs JM, Stessman J. New anticoagulant drugs among elderly patients is caution necessary?: comment on "the use of dabigatran in elderly patients". Arch Intern Med 2011; 171: 1287-8.
15. Sawyer et al. P-glycoprotein: why is it significant? Pharm J 2011; 286: 295.
16. Beasley BN et al. Anticoagulant options - why the FDA approved a higher but not a lower dose of dabigatran. N Engl J Med 2011; 364: 1788-90.
17. Pugh D et al. Attitudes of physicians regarding anticoagulation for atrial fibrillation: a systematic review. Age Ageing 2011; doi:10.1093/ageing/afr097.
18. Gallagher AM et al. Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis? J Thromb Haemost 2008; 6: 1500-6.
19. West Yorkshire Cardiac Network, 2011 Economic appraisal of dabigatran etexilate 150mg compared warfarin or aspirin in patients with atrial fibrillation. Updated report [online]. Available: http://www.yorksandhumberhearts.nhs.uk/upload/WYCN/Dabigatran/YHEC%20Dabigatran%20Feb%202011.pdf [Accessed 22 September 2011].
20. Scottish Medicines Consortium, 2011. Dabigatran etexilate 110mg and 150mg hard capsules (Pradaxa) SMC No. (672/11)[online]. Available: http://www.scottishmedicines.org.uk/files/advice/dabigatran_Pradaxa_FINAL_August_2011_Amended_05.09.11_for_website.pdf [Accessed 22 September 2011].